B
Market Data
$26.71−$0.32 (−1.18%)
BRVE · Last trade
Prev Close
$27.03
Range (29d)
$25.50 – $29.41
Recent Filings
- SCHEDULE 13D/A33.5 KBBraveheart Bio, Inc.Sep 10, 5:07 PM ET·0000947871-26-000860
- 10-Q6.2 MBBraveheart Bio, Inc.Sep 8, 4:08 PM ET·0001628280-26-060905
- 8-K367.4 KBBraveheart Bio, Inc.Sep 8, 4:06 PM ET·0001628280-26-060904
- SCHEDULE 13D34.4 KBBraveheart Bio, Inc.Aug 18, 4:59 PM ET·0000947871-26-000814
- SCHEDULE 13D38.2 KBBraveheart Bio, Inc.Aug 14, 4:55 PM ET·0001889476-26-000004
- SCHEDULE 13G30.1 KBBraveheart Bio, Inc.Aug 14, 4:24 PM ET·0001231919-26-000910
- 8-K221.2 KBBraveheart Bio, Inc.Aug 7, 4:14 PM ET·0001628280-26-054842
- S-1/A14.3 MBBraveheart Bio, Inc.Jul 30, 6:08 AM ET·0001628280-26-050756
- S-114.5 MBBraveheart Bio, Inc.Jul 14, 5:59 PM ET·0001628280-26-048213
Insiders
10- Agarwala VineetaDirector
- Anderson Michele A.Chief Development Officer
- Andreessen Marc L10% Owner
- Bos JasperDirector
- Chimovits ErezDirector, 10% Owner
- Coloma Jason VDirector
- Forbion Growth III Management B.V.10% Owner
- Forbion Growth Opportunities Fund III Cooperatief U.A.10% Owner
- HOROWITZ BENJAMIN A10% Owner
- Jiangsu Hengrui Pharmaceuticals Co., Ltd.10% Owner
Tickers
Addresses
business
ONE LETTERMAN DR. BLDG. A, STE. A4-300
SAN FRANCISCO, CA, 94129
mailing
ONE LETTERMAN DR. BLDG. A, STE. A4-300
SAN FRANCISCO, CA, 94129